Next Article in Journal
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?
Next Article in Special Issue
Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination
Previous Article in Journal
Optional Vaccines in Children—Knowledge, Attitudes, and Practices in Romanian Parents
Previous Article in Special Issue
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
 
 
Review

Article Versions Notes

Vaccines 2022, 10(3), 405; https://doi.org/10.3390/vaccines10030405
Action Date Notes Link
article xml file uploaded 8 March 2022 03:30 CET Original file -
article xml uploaded. 8 March 2022 03:30 CET Update https://www.mdpi.com/2076-393X/10/3/405/xml
article pdf uploaded. 8 March 2022 03:30 CET Version of Record https://www.mdpi.com/2076-393X/10/3/405/pdf
article html file updated 8 March 2022 03:32 CET Original file -
article html file updated 1 August 2022 04:32 CEST Update https://www.mdpi.com/2076-393X/10/3/405/html
Back to TopTop